Covance Tissue Sample Stockpile Is Possible Asset For Genomics Research

Covance sees its stockpile of tissue samples from past clinical trials as a potential asset for building a genomics testing business in the future, the clinical research organization indicated during its second quarter earnings conference call July 26.